Biochemistry of demyelination

Brain Pathology

Volumn 6, Issue 3, 1996, Pages 231-242

  Cuzner, M L ^a   Norton, W T ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DINITRO ORTHO CRESOL; MYELIN PROTEIN; PROTEINASE;

BIOCHEMISTRY; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; DEMYELINATION; HUMAN; MULTIPLE SCLEROSIS; MYELIN SHEATH;

EID: 0030055022     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.1996.tb00852.x     Document Type: Conference Paper

References (110)

1. Adams CWM, Davison AN, Gregson NA. (1963) Enzyme inactivity of myelin: Histochemical and biochemical evidence. J Neurochem 10: 383-390
2. Alling C, Vanier M (1971) Lipid alterations in apparently normal white matter in multiple sclerosis Brain Res 35: 325-336
3. Ansell GB, Spanner S (1968) Plasmalogenase activity in normal and demyelinating tissue of the CNS. Biochem J 108: 207-209
4. Banik NL, Gohil K, Davison AN (1976) The action of snake venom, phospholipase A and trypsin on purified myelin in vitro Biochem J 159 273-277
5. Benjamins JA (1984) Protein Metabolism of Oligodendroglial Cells In Vivo. In: Oligodendroglia, Norton WT (ed) Chapter 3, pp. 87-124, Plenum Press: New York
6. Benjamins JA, Smith ME (1984) Metabolism of myelin. In: Myelin, 2nd Edition, Morell P (ed.), pp. 225-249, Plenum New York
7. Bever CT, Whitaker JN (1985) Proteinases in inflammatory demyelinating disease Springer Semi Immunopathol 8. 235-250
8. Blakemore WF, Eames RA, Smith KJ, McDonald WI (1977) Remyelination in the spinal cord of the cat following intraspinal injections of lysolecithin. J Neurol Sci 33. 31-43
9. Boison D, Stoffel W (1994) Disruption of the compacted myelin sheath of axons of the central nervous system in proteolipid protein-deficient mice. Proc Nat Acad Sci USA 91: 11709-11713
10. Bornstein MB, Raine CS (1976) The initial structural lesion in serum - induced demyelination in vitro. Lab Invest 35. 391-400
11. Braun PE (1984) Molecular organization of myelin. In. Myelin, 2nd Edition, Morell P (ed.), pp. 97-113, Plenum: New York
12. Brosnan CF, Bornstein MB, Bloom BR (1981) The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis. J Immunol 126 614-620
13. Brosnan CF, Cammer W, Bloom BR, Norton WT (1980) Initiation of primary demyelination in vivo by a plasminogen activator (urokinase). J Neuropathol Exp Neurol 39.344
14. Brosnan CF, Cammer W, Norton WT, Bloom BR (1980) Proteinase inhibitors suppress the development of experimental allergic encephalomyelitis Nature 285: 235-237
15. Brunner C, Lassmann H, Waehneldt TV, Matthieu JM, Linington C (1989) Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein, and 2′,3′-cyclic nucleotide 3′-phosphodiesterase in the CNS of adult rats. J Neurochem 52: 296-304
16. Cammer W, Bloom BR, Norton WT, Gordon S (1978) Degradation of basic protein in myelin by neutral proteinases secreted by stimulated macrophages: a possible mechanism of inflammatory demyelination. Proc Natl Acad Sci USA 75. 1554-1558
17. Cammer W, Brosnan CF, Basile C, Bloom BR, Norton WT (1986) Complement potentiates the degradation of myelin proteins by plasmin: implications for a mechanism of inflammatory demyelination. Brain Res 364: 91-101
18. Cammer W, Fredman T, Rose AL, Norton WT (1976) Brain carbonic anhydrase: activity in isolated myelin and the effect of hexachlorophene J Neurochem 27: 165-171
19. Campagnoni AT, Pribyl TM, Campagnoni CW, Kampf K, Amur-Umarjee S, Landry CF, Handley VW, Newman SL, Garbay B, Kitamura K (1993) Structure and developmental regulation of Golli-mbp, a 105-kilobase gene that encompasses the myelin basic protein gene and is expressed in cells in the oligodendrocyte lineage in the brain J Biol Chem 268 4930-4938
20. Compston DAS, Cuzner ML, Davison AN (1986) Clinical features and pathophysiology of demyelinating disease. In Clinical Neurochemistry, Bachelard HS, Lund GC, Marsden CD (eds), pp 77-189, London Academic Press
21. Compston DAS, Morgan BP, Campbell AK, Wilkins P, Cole G, Thomas ND, Jasani B (1989) Immunocytochemical localization of the terminal complement complex in multiple sclerosis. Neuropathol Appl Neurobiol 15: 307-316
22. Compston A, Scolding N, Wren D, Noble M (1991) The pathogenesis of demyelinating disease: insights from cell biology. TINS 14: 175-181
23. Cuzner ML. (1996) Proteases in Demyelination. In: Inflammatory Mediators in Degenerating Disorders of the CNS and PNS, Hartung P. (ed.) in press.
24. Cuzner ML, Barnard RO, MacGregor BJL, Borshell NJ, Davison AN (1976) Myelin composition in acute and chronic multiple sclerosis in relation to cerebral lysosomal activity. J Neurol Sci 29: 323-334
25. Cuzner ML, Davison AN, Rudge P (1978) Proteolytic enzyme activity of blood leucocytes and CSF in multiple sclerosis. Ann Neurol 4: 337-344
26. Dal Canto MC, Wisniewski HM, Johnson AB, Brostoff SW, Raine CS (1975) Vesicular disruption of myelin in autoimmune demyelination. Lab Invest 31: 313-319
27. Davison AN, Peters A (1970) Myelination, Charles C Thomas: Springfield, Illinois
28. Dewille JW, Horrocks LA (1992) Synthesis and turnover of myelin phospholipids and cholesterol. In: Myelin: Biology and Chemistry, Martenson RE (ed.), pp 213-234, CRC Press: Boca Raton, Florida
29. Dubois-Dalcq M. (1995) Regeneration of oligodendrocytes and myelin. Trends Neurosci 18: 289-291
30. Dyer CA. (1993) Novel oligodendrocyte transmembrane signaling systems Mol Neurobiol 7: 1-22
31. Dyer CA, Hickey WF, and Geisert EE, Jr. (1991) Myelin/oligodendrocyte-specific protein: A novel surface membrane protein that associates with microtubules. J Neurosci Res 28: 607-613
32. Einstein ER, Csejtey J, Dalal KB, Adams CWM, Bayliss OB, Hallpike JF (1972) Proteolytic activity and basic protein loss in and around multiple sclerosis plaques: Combined biochemical and histochemical observations. J Neurochem 19: 653-662
33. Einstein ER, Dalal KB, Csejtey J (1970) Increased protease activity and changes in basic proteins and lipids in multiple sclerosis plaques. J Neurol Sci 11: 109-121
34. Eng LF, Vanderhaeghen JJ, Bignami A, Gerstl B (1971) An acidic protein isolated from fibrous astrocytes Brain Res 28: 351-354
35. Fisher M, Plante GM, Doyle EM (1993) Inhibition of inflammatory cell-mediated myelin oxidation and interleukin-1ß generation by a 21-aminosteroid, U74500A. J Neurol Sci 119: 189-194
36. Gardinier MV, Amiguet P, Linington C, Matthieu JM (1992) Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily. J Neurosci Res 33: 177-187
37. Gehrmann J, Gold R, Linington C, Lannes-Vieira J, Wekerle H, Kreutzberg GW. (1993) Microglial involvement in experimental autoimmune inflammation of the central and peripheral nervous system. Glia 7: 50-59
38. Gehrmann J, Matsumoto Y, Kreutzberg GW. (1995) Microglia: Intrinsic immuneffector cell of the brain. Brain Res Rev 20: 269-287
39. Glynn P, Gilbert HM, Newcombe J, Cuzner ML, (1982) Analysis of immunoglobulin G in multiple sclerosis brain quantitative and isoelectric focusing studies. Clin Exp Immunol 48: 102-110
40. Glynn P, Linington C (1989) Cellular and molecular mechanisms of autoimmune demyelination in the central nervous system. CRC Critical Rev Neurobiol 4: 367-385
41. Goldenberg PZ, Kwon EE, Benjamins JA, Whitaker JN, Quarles RH, Prineas JW (1989) Opsonization of normal myelin by anti-myelin antibodies and normal serum. J Neuroimmunol 23: 157-166
42. Goldman JE (1992) Regulation of oligodendrocyte differentiation. TINS 15: 359-362
43. Golly F, Larocca JN, Ledeen RW (1990) Phosphoinositide breakdown in isolated myelin is stimulated by GTP analogues and calcium. J Neurosci Res 27: 342-348
44. Herndon RM, Kasckow J (1978) Electron microscopic studies of cerebrospinal fluid sediment in demyelinating disease. Ann Neurol 4: 515-523
45. Hirsch HE, Duquette P, Parks ME (1976) The quantitative histochemistry of multiple sclerosis plaques: acid proteinase and other acid hydrolases. J Neurochem 26: 505-512
46. Hirsch HE, Parks ME (1979) A thiol proteinase highly elevated in and around the plaques of multiple sclerosis: Some biochemical parameters of plaque activity and progression. J Neurochem 32: 505-513
47. Hunter MI, Nlemadim BC, Davidson DLW. (1985) Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis patients. Neurochem Res 10: 1645-1652
48. Itoyama Y, Sternberger NH, Webster H (1980) immunocytochemical observations on the distribution of myelin-associated glycoprotein and myelin basic protein in multiple sclerosis lesions Ann Neurol 7: 167-177
49. Jeffery ND, Blakemore WF (1995) Remyelination of mouse spinal cord axons demyelinated by local injection of lysolecithin. J Neurocytol 24. 775-781
50. Johnson D, Sato S, Quarles RH, Webster H, Brady RO (1981) Radioimmunoassay for the myelin-associated glycoprotein in multiple sclerosis brain. J Neuropathol Exp Neurol 40. 308-
51. Jordan CA, Friedrich VL, deFerra F, Weismiller DG, Holmes KV, Dubois-Dalcq M (1990) Differential exon expression in myelin basic protein transcripts during central nervous system (CNS) remyelination. Cell Mol Neurobiol 10: 3-17
52. Kamholz J, Toffenetti J, Lazzarini RA (1988) Organization and expression of the human myelin basic protein gene. J Neurosci Res 21. 62-70
53. Kirschner DA, Blaurock AE (1991) Organization, phylogenetic variations and dynamic transitions of myelin In: Myelin: Biology and Chemistry, Martenson RE (ed.), pp. 413-448, CRC Press: Boca Raton, Florida
54. Konat GW, Wiggins RC (1985) Effect of reactive oxygen species on myelin membrane proteins. J Neurochem 45: 1113-1118
55. Lampert PW (1965) Demyelination and remyelination in experimental allergic encephalomyelitis. further electron microscopic observations. J Neuropathol Exp Neurol 24: 371-385
56. Larocca JN, Golly F, Ledeen RW (1991) Detection of G proteins in purified bovine brain myelin. J Neurochem 57: 30-38
57. Larocca JN, Ledeen RW (1993) Hydrolysis of inositol trisphosphate by purified rat brain myelin J Neurochem 60. 1864-1869
58. Law MJ, Martenson RE, Deibler GE (1984) Cleavage of rabbit myelin basic protein by thrombin. J Neurochem 42: 559-568
59. Ledeen RW (1992) Enzymes and receptors of myelin. In: Myelin: Biology and Chemistry, Martenson RE (ed), pp. 531-570, CRC Press: Boca Raton, Florida
60. Lees MB, Bizzozero OA (1991) Structure and acylation of proteolipid protein. In: Myelin: Biology and Chemistry, Martenson RE (ed.), pp. 237-255, CRC Press: Boca Raton, Florida
61. Lees MB, Brostoff SW (1984) Proteins of myelin. In: Myelin, 2nd Edition, Morell P (ed.), pp. 197-217, Plenum: New York
62. Li C, Tropak MB, Gerlai R, Clapoff S, Abramow-Newerly W, Trapp B, Peterson A, Roder J (1994) Myelination in the absence of myelin-associated glycoprotein. Nature 369: 747-750
63. Li H, Newcombe J, Cuzner ML (1993) Characterisation and distribution of phagocytic macrophages in MS plaques. Neuropathol Appl Neurobiol 19: 214-223
64. Martenson RE (ed.) (1992) Myelin Biology and Chemistry, CRC Press Boca Raton
65. McGeer PL, McGeer EG (1995) The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Rev 21: 195-218
66. Mikol DD, Gulcher JR, Stefansson K (1990) The oligodendrocyte-myelin glycoprotein belongs to a distinct family of proteins and contains the HNK-1 carbohydrate. J Cell Biol 110: 471-479
67. Mikoshiba K, Okano H, Tamura T, Ikenaka K (1991) Structure and function of myelin protein genes Annu Rev Neurosci 14: 201-217
68. Montag D, Giese KP, Bartsch U, Martini R, Lang Y, Bluthmann H, Karthigasan J, Kirschner DA, Wintergerst ES, Nave K-A, Zielasek J, Toyka KV, Lipp H-P, Schachner M (1994) Mice deficient for the myelin-associated glycoprotein show subtle abnormalities in myelin. Neuron 13: 229-246
69. Morell P (ed.) (1884) Myelin, 2nd Edition, Plenum Press: New York
70. Morell P, Quarles RH, Norton WT (1994) Myelin formation, structure, and biochemistry In: Basic Neurochemistry: Molecular, Cellular, and Medical Aspects, Siegel GJ, Agranoff, BW, Albers, RW, Molinoff, PB (eds.). Chapter 6, pp. 117-141, Raven Press: New York
71. Mosley K, Cuzner ML (1996) Receptor-mediated phagocytosis of myelin by macrophages and microglia: effect of opsonization and receptor blocking agents. Neurochem Res 21. 481-487
72. Newcombe J, Cuzner ML, Roytta M, Frey H (1980) White matter proteins in multiple sclerosis. J Neurochem 34: 700-708
73. Newcombe J, Glynn P, Cuzner ML (1982) The immunological identification of brain proteins on cellulose nitrate in human demyelinating disease. J Neurochem 38: 267-274
74. Newcombe J, Li H, Cuzner ML (1994) Low density lipoprotein uptake by macrophages in multiple sclerosis plaques: Implications for pathogenesis. Neuropathol Appl Neurobiol 20: 152-162
75. Newcombe J, Woodroofe MN, Cuzner ML (1986) Distribution of glial fibrillary acidic protein in gliosed human white matter. J Neurochem 47: 1713-1719
76. Newman S, Saito M, Yu RK (1995) Biochemistry of myelin proteins and enzymes In: Neuroglia, Kettenman H, Ransom BR (eds.), pp 535-554, Oxford: New York
77. Norton WT (1980) Myelin enzymes: Indicators of non-insulating functions. In: Search for the Cause of Multiple Sclerosis and other Chronic Diseases of the Central nervous System, Boese A.(ed.) pp. 64-75, Verlag Chemie: Weinheim
78. Norton WT (1996) Do oligodendrocytes divide? Neurochem Res 21: 493-501
79. Norton WT, Cammer W (1984) Isolation and characterization of myelin. In. Myelin, Morell P (ed.), pp. 147-180, Plenum: New York
80. Norton WT, Cammer W (1984) Chemical pathology of diseases involving myelin. In: Myelin, Morell P (ed.), pp. 369-403, Plenum: New York
81. Offner H, Konat G (1983) Myelin changes induced by incubation of brain slices with serum Neurochem Int 5: 45-49
82. Pescovitz MD, Paterson PY, Lorand L (1978) Serum degradation of myelin basic protein with loss of encephalitogenic activity: Evidence for an enzymatic process. Cell Immunol 39: 355-365
83. Pfeiffer SE, Warrington AE, Bansal R (1993) The oligodendrocyte and its many cellular processes. Trends Cell Biol 3: 191-197
84. Piddlesden SJ, Lassmann H, Zimprich F, Morgan BP, Linington C (1993) The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am J Pathol 143: 555-564
85. Prineas JW (1975) Pathology of the early lesions in multiple sclerosis. Hum Pathol 6: 531-554
86. Prineas JW (1985) The neuropathology of multiple sclerosis. In: Handbook of Clinical Neurology, Koetsier JC (ed.), pp. 213-257, Elsevier Science Publishing: New York
87. Prineas JW, Connell F (1978) The fine structure of chronically active multiple sclerosis plaques. Neurology 28: 68-75
88. Prineas JW, Graham JS (1981) Multiple Sclerosis: Capping of surface immunoglobulin G on macrophages engaged in myelin breakdown. Ann Neurol 10: 149-158
89. Quarles RH, Colman DR, Salzer JL, Trapp BD (1992) Myelin-associated glycoprotein: Structure-function relationships and involvement in neurological diseases. In: Myelin: Biology and Chemistry, Martenson RE (ed.), pp. 413-448, CRC Press: Boca Raton, Florida
90. Sato S, Quarles RH, Brady RO (1981) Susceptibility of the myelin-associated glycoprotein and glycoprotein and basic protein to a neutral protease in highly purified myelin from human and rat brain. J Neurochem 39: 97-105
91. Silberberg DH, Manning MC, Schreiber AD (1984) Tissue culture demyelination by normal human serum. Ann Neurol 15: 575-580
92. Silverman BA, Carney DF, Johnston CA, Vanguri P, Shin ML (1984) Isolation of membrane attack complex of complement from myelin membranes treated with serum complement. J Neurochem 42. 1024-1030
93. Smith ME, Amaducci LA (1982) Observations on the effects of protease inhibitors on the suppression of experimental allergic encephalomyelitis. Neurochem Res 7: 541-554
94. Smith ME, Benjamins JA (1984) Model systems for study of perturbations of myelin metabolism In Myelin, Morell P (ed.) Chapter 13, pp. 441-487, Plenum Press: New York
95. Sprinkle TJ (1989) 2′3′-cyclic nucleotide 3′' -phosphodiesterase, an oligodendrocyte-schwann cell and myelin-associated enzyme of the nervous system. CRC Critical Rev Neurobiol 4. 235-301
96. Timsit S, Martinez S, Allinquant B, Peyron F, Puelles L, Zalc B (1995) Oligodendrocytes originate in a restricted zone of the embyonic ventral neural tube defined by DM-20 mRNA expression. J Neurosci 15:1012-1024
97. Tsukada Y, Kurihara T (1992) 2′-3′-Cyclic nucleotide 3′-phosphodiesterase: Molecular characterization and possible functional significance. In Myelin: Biology and Chemistry, Martenson RE (ed.), pp. 449-480, CRC Press: Boca Raton, Florida
98. Ulvestad E, Williams K, Vedeler C, Antel J, Nyland H, Mork S, Matre R (1994) Reactive microglia in multiple sclerosis lesions have an increased expression of receptors for the Fc part of IgG J Neurol Sci 121: 125-131
99. Unkeless JC, Gordon S, Reich E (1974) Secretion of plasminogen activator by stimulated macrophages. J Exp Med 139: 834-850
100. Voskuhl RR, McFarlin DE, Tranquill LR, Deibler G, Stone R, Maloni H, McFarland HF (1993) A novel candidate autoantigen in a multiplex family with multiple sclerosis: Prevalence of T-lymphocytes specific for an MBP epitope unique to myelination. J Neuroimmunol 46: 137-144
101. Walsh MJ, Tourtellotte WW (1986) Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA and IgM in multiple sclerosis J Exp Med 163: 41-53
102. Weidenheim KM, Epshteyn I, Rashbaum WK, Lyman WD (1993) Neuroanatomical localization of myelin basic protein in the late first and early second trimester human foetal spinal cord and brainstem J Neurocytology 22 507-516
103. Wisniewski HM, Bloom BR (1975) Primary demyelination as a nonspecific consequence of a cell mediated immune reaction. J Exp Med 141: 346-359
104. Wolfgram F (1972) Chemical theories of the demyelination in multiple sclerosis. In: Wolfgram F, Ellison GW, Stevens JG, Andrews JM (eds.), Multiple Sclerosis, Immunology, Virology and Ultrastructure. New York: Academic Press, pp 173-182
105. Yanagisawa K, Ishigro H, Kaneko K, Miyatake T (1990) Acetazolamide inhibits the recovery from triethyl tin intoxication: Putative role of carbonic anhydrase in dehydration of central myelin. Neurochem Res 15: 483-486
106. Yanagisawa K, Querles RH, Johnson D, Brady RO, Whitaker JN (1985) A derivative of myelin-associated glycoprotein in cerebrospinal fluid of normal subjects and patients with neurological disease. Ann Neurol 18. 464-469
107. Yarom Y, Naparstek Y, Lev-Ram V, Holoshitz J, Ben-Nun A, Cohen IR (1983) Immunospecific inhibition of nerve conduction by T lymphocytes reactive to basic protein of myelin. Nature 303: 246-247
108. Young PR, Zygas AP (1986) Secretion of lactic acid by peritoneal macrophages during extracellular phagocytosis - The possible role of local hyperacidity in inflammatory demyelination. J Neuroimmunol 15: 295-308
109. Yu RK, Ledeen RW, Eng LF (1974) Ganglioside abnormalities in multiple sclerosis. J Neurochem 23: 169-174
110. Yu RK, Ueno K, Glaser GH, Tourtellotte WW (1982) Lipid and protein alterations of spinal cord and cord myelin of multiple sclerosis. J Neurochem 39: 464-477